Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

XENEXENE
Showing 7 of 29 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in XENON PHARMACEUTICALS INC

TWO SIGMA INVESTMENTS, LP holds 1.6M shares of XENE (XENON PHARMACEUTICALS INC), worth $99.2M as of 2026-Q2. The position was increased (+171.1% shares). XENE represents 0.1% of TWO SIGMA INVESTMENTS, LP's portfolio.

Current Value

$99.2M

Current Shares

1.6M

Total Value Change

+$89.6M

Total Shares Change

+1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.6M
+171.1%
$99.2M0.1%$60.36
48
2026-Q1
Increased
606,085
+38.8%
$35.2M0.0%$43.79
38
2025-Q4
New
436,743
-
$19.6M0.0%$44.12
39
2025-Q2
Exited
0
-100.0%
$00.0%$32.40
0
2025-Q1
Decreased
236,983
-13.3%
$8M0.0%$34.26
0
2024-Q4
Increased
273,352
+12.2%
$10.7M0.0%$38.53
31
2024-Q3
Increased
243,579
+24.8%
$9.6M0.0%$38.65
34

Other major holders of XENE: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used